1Dolnan KM, Gans RO, Vervaat TJ, et al. Vascutitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy [ J ].Lancet, 1993, 342: 651-652.
2Nob KY, Asari T, Hamada N, et al. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmitic antibody(MPO-ANCA) in Graves, disease patients treated with propylthiouracil and the relationship between MOP-ANCA and clinical mangestations [J ]. Clin Endocrinol,2001, 54: 651-654.
3Gunton JE, Steiel J, Clifton-Bligh P, et al. Prevalence of positive antineutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication[J ]. Eur J Endocrinol, 2000, 142:587.
10Savige J, Davies D, Falk RJ, et al. Antineutrophil cytoplasmic antibodlies and associated diseases: a review of the clinical and laboratory feature[J]. Kedney Ira, 2000, 57: 846-862.
4[1]Bartalena L, Bogazzi F, Martino E. Adverse effects of thyroid hormone preparations and antithyroid drugs[J]. Drug Saf,1996,15(1):53-56.
5[2]Tamai H, Sudo T, Kimura A,et al. Association between the DRB1*08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease[J]. Ann intern Med,1996,124(5):490-494.
7[4]Chien MN, Wan CH, Tsan KW. Methimazole-induced agranulocytosis treated with recombinant human granulocyte[J]. Chung Hua I Hsueh Tsa Chin Taipei,1995,56(5):351-355.
8[5]Andres E, Maloisel F, Kurtz JE,et al. Do hematopoietic growth factors have a role in the treatment of drug-induced agranulocytosis?[J]. Rev Med Interne,2000,21(7):580-585.
10[7]Hara H, Ban Y, Sato R,et al. Change in serum G-CSF levels in patients with Graves disease by treatment with methimazole[J]. Nippon Naibunpi Gakkai Zasshi,1992,68(10):1121-1129.
4Dai WX,Zhang JD,Zhan SW,et al.Retrospective analysis of 18 cases of antithyroid drug(ATD)-induced agranulocytosis[J].Endocr J,2002,49(1):29-33.
5Tajiri J,Noguchi S.Antithyroid drug induced agranulocytosis:how has granulocyte colony stimulating factor changed therapy[J].Thyroid,2005,15(3):292-297.
6Juliá A,Olona M,Bueno J,et al.Drug induced agranulocytosis:prognostic factors in series of 168 episodes[J].Br J Haematol,1991,79(3):366-371.
7Tamai H, Sudo T, Kimura A, et al. Association between the DRB1 * 08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease. Ann Intern Med, 1996,124 (5) :490-494.
